AU2008322437B2 - Use of nitrite salts in chronic ischemia - Google Patents
Use of nitrite salts in chronic ischemia Download PDFInfo
- Publication number
- AU2008322437B2 AU2008322437B2 AU2008322437A AU2008322437A AU2008322437B2 AU 2008322437 B2 AU2008322437 B2 AU 2008322437B2 AU 2008322437 A AU2008322437 A AU 2008322437A AU 2008322437 A AU2008322437 A AU 2008322437A AU 2008322437 B2 AU2008322437 B2 AU 2008322437B2
- Authority
- AU
- Australia
- Prior art keywords
- tissue
- nitrite
- ischemic
- chronic
- ischemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US315007P | 2007-11-15 | 2007-11-15 | |
| US61/003,150 | 2007-11-15 | ||
| PCT/US2008/083830 WO2009065142A2 (en) | 2007-11-15 | 2008-11-17 | Use of nitrite salts in chronic ischemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008322437A1 AU2008322437A1 (en) | 2009-05-22 |
| AU2008322437B2 true AU2008322437B2 (en) | 2013-11-07 |
Family
ID=40639493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008322437A Ceased AU2008322437B2 (en) | 2007-11-15 | 2008-11-17 | Use of nitrite salts in chronic ischemia |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9649334B2 (enExample) |
| EP (1) | EP2219657A4 (enExample) |
| JP (2) | JP5795165B2 (enExample) |
| CN (1) | CN101939014B (enExample) |
| AU (1) | AU2008322437B2 (enExample) |
| IL (1) | IL205720A (enExample) |
| WO (1) | WO2009065142A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| US20120237617A1 (en) * | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| US20130209584A1 (en) * | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| IN2012DN03428A (enExample) | 2009-10-14 | 2015-10-23 | Theravasc Inc | |
| ES2741146T3 (es) * | 2013-02-20 | 2020-02-10 | The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College | Formulaciones farmacéuticas de nitrio y sus usos |
| US10517817B2 (en) | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
| WO2017132275A1 (en) | 2016-01-27 | 2017-08-03 | Syk Technologies, Llc | Nitric oxide topical application apparatus and methods |
| KR20200083974A (ko) * | 2017-09-05 | 2020-07-09 | 엑셀 메드, 엘엘씨 | 허혈 치료용 헤파린 조성물 |
| CA3123524C (en) | 2019-01-02 | 2024-01-23 | Celagenex Research (India) Pvt. Ltd. | Synergistic nutritional compositions for pain management |
| US12459820B2 (en) | 2020-06-11 | 2025-11-04 | J. W. Randolph Miller | Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060182815A1 (en) * | 2004-07-09 | 2006-08-17 | Use of nitrite salts for the treatment of cardiovascular conditions |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2914446A (en) | 1958-06-26 | 1959-11-24 | Upjohn Co | Nitrite stabilized ascorbic acid-cyanocobalamin compositions |
| US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
| IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| US20110196039A9 (en) | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
| US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
| US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| US7015876B1 (en) | 1998-06-03 | 2006-03-21 | Lear Corporation | Heads-up display with improved contrast |
| US6103275A (en) * | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
| EP1105146A1 (en) | 1998-07-14 | 2001-06-13 | Paracelsian, Inc. | Method for identifying and confirming consistent bio-functionality of natural compositions |
| EP1146862B1 (de) | 1999-01-29 | 2003-04-23 | Disphar International B.V. | Pharmazeutische zusammensetzungen |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
| WO2002009727A1 (en) * | 2000-07-28 | 2002-02-07 | Bioenergy, Inc. | Compositions and methods for improving cardiovascular function |
| GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| US20030125714A1 (en) | 2001-12-18 | 2003-07-03 | Edgren David Emil | Dosage form for time-varying patterns of drug delivery |
| EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| CA2379211A1 (fr) | 2002-03-28 | 2003-09-28 | Institut De Cardiologie De Montreal | Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase) |
| AU2004255268B2 (en) * | 2003-07-09 | 2010-04-01 | Loma Linda University | Use of nitrite salts for the treatment of cardiovascular conditions |
| WO2005018561A2 (en) | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| WO2005023189A2 (en) * | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| EP1883416A4 (en) | 2005-05-24 | 2013-06-12 | Wellgen Inc | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS RELATED TO INFLAMMATION |
| MX2008010127A (es) | 2006-02-10 | 2009-03-05 | Mannatech Inc | Formulaciones de suplementos dieteticos multivitaminicos y multiminerales naturales, para su absorcion mejorada y uso biologico. |
| GB0607402D0 (en) * | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| WO2007149520A2 (en) * | 2006-06-21 | 2007-12-27 | Albert Einstein College Of Medicine Of Yeshiva University | Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| EP3159000B1 (en) * | 2007-02-26 | 2025-05-21 | HeartBeet Ltd. | Performance enhancing composition |
| KR20100014853A (ko) | 2007-02-26 | 2010-02-11 | 존 런드버그 | 아질산염 및 질산염의 신규 용도 및 이를 함유하는 조성물 |
| WO2008153762A2 (en) | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| JP2011507968A (ja) | 2007-12-27 | 2011-03-10 | エイヤーズ ファーマシューティカルズ、インク. | エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用 |
| WO2010036236A1 (en) | 2008-09-23 | 2010-04-01 | Baker Hughes Incorporated | Anchor assembly |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| US20120237617A1 (en) | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| US20130209584A1 (en) | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| IN2012DN03428A (enExample) | 2009-10-14 | 2015-10-23 | Theravasc Inc | |
| US20140127329A1 (en) | 2011-03-31 | 2014-05-08 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
| US20140112983A1 (en) | 2011-04-14 | 2014-04-24 | Theravasc Inc. | Nitrite compositions and uses thereof |
| US9294956B2 (en) | 2011-12-29 | 2016-03-22 | Qualcomm Incorporated | Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications |
| ES2741146T3 (es) * | 2013-02-20 | 2020-02-10 | The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College | Formulaciones farmacéuticas de nitrio y sus usos |
-
2008
- 2008-11-17 CN CN200880116483.4A patent/CN101939014B/zh not_active Expired - Fee Related
- 2008-11-17 WO PCT/US2008/083830 patent/WO2009065142A2/en not_active Ceased
- 2008-11-17 AU AU2008322437A patent/AU2008322437B2/en not_active Ceased
- 2008-11-17 JP JP2010534267A patent/JP5795165B2/ja active Active
- 2008-11-17 US US12/741,436 patent/US9649334B2/en active Active
- 2008-11-17 EP EP08849380.4A patent/EP2219657A4/en not_active Withdrawn
-
2010
- 2010-05-12 IL IL205720A patent/IL205720A/en active IP Right Grant
-
2014
- 2014-05-08 JP JP2014097072A patent/JP5908527B2/ja not_active Expired - Fee Related
-
2017
- 2017-04-10 US US15/483,187 patent/US10864229B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060182815A1 (en) * | 2004-07-09 | 2006-08-17 | Use of nitrite salts for the treatment of cardiovascular conditions |
Non-Patent Citations (1)
| Title |
|---|
| Jung, KH et al (2006) Stroke. Volume 37. Pages 27442750 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20110311653A1 (en) | 2011-12-22 |
| CN101939014B (zh) | 2016-04-27 |
| AU2008322437A1 (en) | 2009-05-22 |
| US10864229B2 (en) | 2020-12-15 |
| US9649334B2 (en) | 2017-05-16 |
| CN101939014A (zh) | 2011-01-05 |
| EP2219657A4 (en) | 2020-01-08 |
| JP5908527B2 (ja) | 2016-04-26 |
| JP2014139255A (ja) | 2014-07-31 |
| IL205720A (en) | 2015-08-31 |
| JP2011503212A (ja) | 2011-01-27 |
| IL205720A0 (en) | 2010-11-30 |
| US20170312310A1 (en) | 2017-11-02 |
| EP2219657A2 (en) | 2010-08-25 |
| JP5795165B2 (ja) | 2015-10-14 |
| WO2009065142A2 (en) | 2009-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10864229B2 (en) | Use of nitrite salts in chronic ischemia | |
| Koneru et al. | Sildenafil‐mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin‐1 | |
| Reid | Osteoporosis treatment: focus on safety | |
| US20190381090A1 (en) | Use of dextran sulfate | |
| US10596188B2 (en) | Use of nitrite salts in treating tissue damage | |
| JP2014533697A (ja) | デフェリプロンを用いた処置方法 | |
| Oh et al. | Effects of remote ischemic preconditioning on regional cerebral oxygen saturation in patients in the beach chair position during shoulder surgery: a double-blind randomized controlled trial | |
| US10772827B2 (en) | Composition for treating apoplexy through nasal administration | |
| WO2011038298A1 (en) | Use of dipyridamole in chronic ischemia | |
| WO2015190989A1 (en) | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject | |
| US20210128596A1 (en) | Compositions and methods for treating septic cardiomyopathy | |
| HK1152657B (en) | Use of nitrite salts in chronic ischemia | |
| HK1152657A (en) | Use of nitrite salts in chronic ischemia | |
| Truong et al. | Sotatercept: a new frontier in pulmonary arterial hypertension treatment | |
| SOLIMAN et al. | Comparison of hemodynamic variables during continuous spinal anesthesia and general anesthesia in high risk cardiac patients: A randomized study | |
| JP2025516717A (ja) | 血管新生を誘発する薬剤 | |
| WO2025056188A1 (en) | Relaxin medication | |
| Fish | The role of angiotensin II on vascular hypertrophy in genetic and renovascular hypertension | |
| Niroomand | Supernormal conduction mimicking a supraventricular capture beat during wide complex tachycardia | |
| Chen | Articles in PresS. Am J Physiol Regul Integr Comp Physiol (May 30, 2012). doi: 10.1152/ajpregu. 00114.2012 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |